ES2388963B1 - Desarrollo y uso de nanoparticulas lipidicas conteniendo edelfosina y otros eteres de fosfolipidos en la terapia antitumoral y antiparasitaria - Google Patents
Desarrollo y uso de nanoparticulas lipidicas conteniendo edelfosina y otros eteres de fosfolipidos en la terapia antitumoral y antiparasitariaInfo
- Publication number
- ES2388963B1 ES2388963B1 ES201130433A ES201130433A ES2388963B1 ES 2388963 B1 ES2388963 B1 ES 2388963B1 ES 201130433 A ES201130433 A ES 201130433A ES 201130433 A ES201130433 A ES 201130433A ES 2388963 B1 ES2388963 B1 ES 2388963B1
- Authority
- ES
- Spain
- Prior art keywords
- edelphosine
- antiparasitary
- antitumoral
- phospholipids
- ethers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201130433A ES2388963B1 (es) | 2011-03-24 | 2011-03-24 | Desarrollo y uso de nanoparticulas lipidicas conteniendo edelfosina y otros eteres de fosfolipidos en la terapia antitumoral y antiparasitaria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201130433A ES2388963B1 (es) | 2011-03-24 | 2011-03-24 | Desarrollo y uso de nanoparticulas lipidicas conteniendo edelfosina y otros eteres de fosfolipidos en la terapia antitumoral y antiparasitaria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2388963A1 ES2388963A1 (es) | 2012-10-22 |
| ES2388963B1 true ES2388963B1 (es) | 2013-09-13 |
Family
ID=46940874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201130433A Expired - Fee Related ES2388963B1 (es) | 2011-03-24 | 2011-03-24 | Desarrollo y uso de nanoparticulas lipidicas conteniendo edelfosina y otros eteres de fosfolipidos en la terapia antitumoral y antiparasitaria |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2388963B1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8586621B2 (en) * | 2006-10-27 | 2013-11-19 | Michael A. Zeligs | Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles |
| CA2746129A1 (en) * | 2008-12-11 | 2010-06-17 | Abraxis Bioscience, Llc | Combination chemotherapy of nanoparticulate taxanes and inhibitors of pro-survival and/or inflammatory signals |
-
2011
- 2011-03-24 ES ES201130433A patent/ES2388963B1/es not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2388963A1 (es) | 2012-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280771A (en) | Lipid nanoparticle compositions and methods for mrna delivery | |
| IL280819A (en) | Adeno-associated virus virions with variant capsid and methods of use thereof | |
| EP2701686A4 (en) | LIPID BINCHES SUPPORTED ON POROUS NANOPARTICLES (PROTOCELLS) FOR TARGETED ADMINISTRATION, AND METHODS OF USE THEREOF | |
| EP3010528A4 (en) | In vivo targeting of cells with ligand-conjugated particles | |
| HRP20190080T1 (hr) | Postupak i formulacija za inhaliranje | |
| SI3552619T1 (sl) | Polipeptidi faktorja IX in načini njihove uporabe | |
| EP3088353B8 (en) | Bilirubin particles and their preparation for use in therapy | |
| EP2861072A4 (en) | NATURAL COMBINED HORMONRY SUB-FORMULATIONS AND THERAPIES | |
| IL226377A0 (en) | Nanoparticle isoflavone compositions & methods of making and using the same | |
| SMT201400146B (it) | Morfolino pirimidine e loro uso in terapia | |
| SI3067358T1 (sl) | Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba | |
| EP3046547A4 (en) | Core and surface modification of mesoporous silica nanoparticles to achieve cell specific targeting in vivo | |
| CO6870033A2 (es) | Compuestos terapéuticos y métodos de uso relacionados | |
| EP2668212A2 (en) | Human antibodies to pcsk9 for use in methods of treating particular groups of subjects | |
| DK2834348T3 (da) | 3d in vitro bifasisk brusk-knogle-konstruktion | |
| PL2780036T3 (pl) | Kompozycje nanocząstek do generowania regulatorowych komórek t i leczenie chorób autoimmunologicznych i innych przewlekłych stanów zapalnych | |
| IL231222B (en) | Preparations containing oxidized phospholipids | |
| IL248319A0 (en) | Methods of delivering weight loss therapy to patients with major depression | |
| BR112012029412A2 (pt) | partículas funcionalizadas e uso destas | |
| BR112013030644A2 (pt) | fosfolipídios contendo ácido(s) nitrocarboxílico(s) da estrutura geral (i), e uso dos mesmos, dispositivo médico e composições biopassivadoras | |
| IL236791A0 (en) | Compositions and methods for producing the compositions for use in colon emptying | |
| EP2670857A4 (en) | 3D CELL DEVELOPMENT ABILITY ANALYSIS | |
| IL229748A0 (en) | Compounds that bind to human β1-adrenoceptor (ß1-ar) and their use in the measurement of ar-a1 autoantibodies | |
| PT2590509T (pt) | Método para a preparação e utilização de biocidas enriquecidos em radicais ativos antes da utilização | |
| BR112015033065A8 (pt) | nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2388963 Country of ref document: ES Kind code of ref document: B1 Effective date: 20130913 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20181015 |